Fresenius SE & Co. KGaA (FRE.DE)
- Previous Close
25.45 - Open
25.55 - Bid 26.61 x --
- Ask 26.63 x --
- Day's Range
25.52 - 26.70 - 52 Week Range
23.93 - 31.22 - Volume
1,964,221 - Avg. Volume
1,115,722 - Market Cap (intraday)
14.988B - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
42.24 - EPS (TTM)
0.63 - Earnings Date May 8, 2024
- Forward Dividend & Yield 0.92 (3.19%)
- Ex-Dividend Date May 18, 2023
- 1y Target Est
35.30
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
www.fresenius.com193,865
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FRE.DE
Performance Overview: FRE.DE
Trailing total returns as of 4/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FRE.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FRE.DE
Valuation Measures
Market Cap
14.33B
Enterprise Value
27.88B
Trailing P/E
40.40
Forward P/E
8.75
PEG Ratio (5yr expected)
0.24
Price/Sales (ttm)
0.64
Price/Book (mrq)
0.75
Enterprise Value/Revenue
1.25
Enterprise Value/EBITDA
10.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.66%
Return on Assets (ttm)
1.21%
Return on Equity (ttm)
0.92%
Revenue (ttm)
22.3B
Net Income Avi to Common (ttm)
353M
Diluted EPS (ttm)
0.63
Balance Sheet and Cash Flow
Total Cash (mrq)
2.57B
Total Debt/Equity (mrq)
80.56%
Levered Free Cash Flow (ttm)
2.25B